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Abstract
Obsessive compulsive disorder (OCD) is a syndrome characterized by recurrent and intrusive thoughts and ritualistic
behaviors or mental acts that a person feels compelled to perform. Twin studies, family studies, and segregation analyses
provide compelling evidence that OCD has a strong genetic component. The SLITRK1 gene encodes a developmentally
regulated stimulator of neurite outgrowth and previous studies have implicated rare variants in this gene in disorders in the
OC spectrum, specifically Tourette syndrome (TS) and trichotillomania (TTM). The objective of the current study was to
evaluate rare genetic variation in SLITRK1 in risk for OCD and to functionally characterize associated coding variants. We
sequenced SLITRK1 coding exons in 381 individuals with OCD as well as in 356 control samples and identified three novel
variants in seven individuals. We found that the combined mutation load in OCD relative to controls was significant
(p= 0.036). We identified a missense N400I change in an individual with OCD, which was not found in more than 1000
control samples (P,0.05). In addition, we showed the the N400I variant failed to enhance neurite outgrowth in primary
neuronal cultures, in contrast to wildtype SLITRK1, which enhanced neurite outgrowth in this assay. These important
functional differences in the N400I variant, as compared to the wildtype SLITRK1 sequence, may contribute to OCD and OC
spectrum symptoms. A synonymous L63L change identified in an individual with OCD and an additional missense change,
T418S, was found in four individuals with OCD and in one individual without an OCD spectrum disorder. Examination of
additional samples will help assess the role of rare SLITRK1 variation in OCD and in related psychiatric illness.
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Introduction
Obsessive-compulsive disorder (OCD) is characterized by
recurrent and intrusive thoughts (obsessions) and ritualistic
behaviors or mental acts (compulsions) that are frequently
performed in response to the obsessional thoughts [1]. Twin and
family studies, the latter including segregation analyses, have
provided compelling evidence that OCD has a strong genetic
component with a complex genetic architecture [2]. It is likely that
OCD is etiologically quite heterogeneous and that rare variants
may account for an appreciable proportion of the genetic liability
to OCD. Family and treatment studies indicate that Tourette
syndrome (TS) and trichotillomania (TTM) are related to OCD
and all three conditions might be considered part of a larger
spectrum of conditions, the so-called OC spectrum [1,3].
Rare variants in the gene SLITRK1 have been associated with
disorders in the OC spectrum [4–6]. In the first description, genetic
analysis of a subject with TS revealed a de novo translocation in 13q
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implicating SLITRK1 as the etiologic mutation [4]. The same study
also described a frameshift mutation in SLITRK1 in an additional
subject with TS, and a recurrent variant in the 39 UTR associated
with altered microRNA binding [4,7]. The frameshift mutation in
the TS proband was inherited from a mother with TTM.
Subsequently, an independent screening of TTM individuals for
mutations in SLITRK1 found two additional missense mutations
that were significantly associated with TTM [5].
SLITRK1 is a member of a family of structurally related
transmembrane proteins characterized by leucine-rich repeat
domains in the extracellular domain and functionally divergent
cytoplasmic domains [8]. The cytoplasmic domain of SLITRK1
distinguishes it from the other members of the SLITRK protein
family (SLITRK 2-6), which may explain its differing role in neurite
outgrowth. SLITRK1 promotes neurite outgrowth while the other
SLITRK proteins tend to inhibit neurite outgrowth [8]. Animal
studies demonstrate that a SLITRK1 knockout mouse has an
anxiety-like phenotype that responds to alpha adrenergic com-
pounds akin to pharmacological treatments of the human OC
spectrum while a knockout model of a related gene, SLITRK5,
results in mice that exhibit OCD-like behaviors, including anxiety
and excessive-self grooming [9,10].
In the current study we investigated the occurrence of rare
variation in SLITRK1 individuals with OCD using a case-control
association methods. We present the results of a genetic screen of
SLITRK1 in OCD and in ethnically matched controls screened for
the absence of OCD (specifically OCD, TS, and TTM). Using two
primary neuronal in vitro model systems we then describe the
functional impact of a rare coding variant identified in the screen.
Results
Genetic Screen
The complete coding region of SLITRK1 was sequenced in 381
unrelated Caucasian individuals with OCD and 356 ethnically
matched controls screened for the absence of disorders of the OC
spectrum (OCD, TS, and TTM) [11]. Additional control samples
used for N4001 genotyping (n= 679) were also matched for
ancestry and had been screened for the absence of OCD and
related disorders [25].
We identified three novel changes in SLITRK1, L63L
(c.189A,G), N400I (c.1099T,A) and T418S (c.1252T,A).
Two of these (L63L and N400I) were identified only once, in
both cases in a subject with OCD; both subjects were heterozygous
for the change. We identified the third heterozygous nonsynon-
ymous change, T418S, in four individuals with OCD and in one
non-OC spectrum control. Each of the identified variants was
found in a highly conserved amino acid (Figure 1).
The combined mutation load for SLITRK1 in OCD (1.57% of
cases) compared to controls (0.28% of controls) was significant
(chi-square statistic (x2) = 3.229, df = 1, p=0.036). Genotyping did
not identify the SLITRK1-N400I variant in 679 additional controls
(x2 = 2.714, df = 1, p=0.0497). In addition, comprehensive review
of the data release from the three 1000 Genomes Project pilots did
not identify the N400I variant in over 1000 low coverage genomes
and whole exomes. [Variants identified in the 1000 Genomes
Project included S49N, S330A, N358I, L380I, T148S, M507V,
and K541R. All were identified in one sample, with the exception
of S330A, which was identified in 9 samples. None of these
variants was observed in our study.]
Phenotypes
The SLITRK1-L63L change was found in one individual with
OCD. She was diagnosed with OCD at age 33, never achieving
full remission while in treatment. Comorbid major depressive
disorder (MDD), social phobia, and post-traumatic stress disorder
(PTSD) were present. She did not have TTM, TS or any other tic
disorder; however, the family history for these disorders is
unknown.
The individual in whom we identified the N400I mutation had
OCD diagnosed at age 47 (age of onset of clinical symptoms is not
clear) and never fully remitted. The individual presented with
obsessive rituals that responded to treatment with amitriptyline,
and later clomipramine. He did not have TTM, TS or any other
tic disorder. Family history for these disorders is unknown.
The SLITRK1-T418S change was found in four individuals with
OCD and in one ethnically matched control. Of the individuals
affected with OCD, one with the T418S mutation had onset of
OCD at 25 years of age. She also had comorbid MDD, panic
disorder with agoraphobia and specific phobia. The second
individual with the T418S mutation had onset of OCD at seven
years of age. In the same year he was also diagnosed with TS.
Neither the TS nor the OCD remitted. The third individual with
the T418S mutation had onset of OCD at six years of age with no
additional comorbidities known. The fourth individual with the
T418S variant had onset of OCD at age 42. She had comorbid
MDD, social phobia, and social anxiety disorder. She did not have
TTM, TS or any other tic disorder. Post hoc analysis of the
ethnically matched control identified with the T418S change
indicated the presence of psychiatric conditions outside of the OC
spectrum, including a grooming disorder (compulsive nail-biting)
and MDD. Pedigrees are given in Figure 2.
Functional Analyses
The nonsynonomous changes in SLITRK1 observed in our study
could potentially impact protein function in deleterious ways.
SLITRK1 has been shown to stimulate neurite outgrowth [8,12]
and we therefore assessed the change in neurite length in primary
rat neurons transfected with various SLITRK1 constructs. In E18
rat hippocampal neurons, over-expressed wildtype SLITRK1
stimulated neurite outgrowth to a significantly greater extent
compared to the over-expressed N400I mutant and empty control
vector at 7 days in vitro (div) (data not shown). At 7 div an
independent student’s t-test demonstrates a significant difference
in the summed total neurite length for wildtype (geometric mean
(M) = 1377.21 mm, 95% confidence interval [CI.95] = 1210.60–
1566.75) relative to the N400I condition (M=1104.08 mm,
CI.95 = 990.83–1233.11); t(112) = 2.637, p=0.0096 (Figure 3a,c).
An additional study of E17 mouse cortical neurons produced
similar results. Specifically, our analyses demonstrated significantly
longer average neurites at 3 div in the SLITRK1 wildtype
(M=1113.9 mm, CI.95 = 992.9–1234.9) compared to the N400I
variant (M=735.4 mm, CI.95 = 665.2–805.5); t(72) = 5.564,
p,0.0001 (Figure 3b,d).
Discussion
By sequencing coding exons of SLITRK1 in 381 individuals
with OCD and 356 controls, we identified two novel missense
variants and one novel synonymous variant in SLITRK1 in seven
individuals. Six of the individuals had OCD (1.57% of OCD) and
one individual was in the comparison group and did not have an
OC spectrum disorder (0.30% of controls). The N400I and L63L
variants were identified, each in a separate OCD individual. The
T418S variant was identified in four OCD samples and in one
screened control. The SLITRK1 mutation burden in OCD cases
relative to controls was significant at p=0.036. This finding
highlights the potentially complex nature of SLITRK1’s influence
SLITRK1 Variation in Obsessive-Compulsive Disorder
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on the heritability and expression for disorders in the OC
spectrum. Previous studies have demonstrated a significant
association between SLITRK1 and TS and TTM, but a number
of independent studies report difficulty in replicating the findings
[4–7,13–21]. Here we add to the literature three additional
variants, one of which (the N400I variant), occurs more frequently
in cases than in controls (p=0.0497) (Figure 1a).
Given the high detection frequency of the T418S variant and its
discovery in an individual without an OCD, we reasoned that the
variant might be common and functionally tolerated in the general
population. Similarly, the L63L variant identified in an individual
with OCD is unlikely to demonstrate easily identifiable functional
consequences, as it does not cause a coding change in the protein.
It remains possible that the L63L variant could have subtle
functional effects such as altering mRNA folding, decreasing
mRNA translation or impacting posttranslational modifications of
the protein, consistent with literature that demonstrates functional
effects of synonymous mutations in the schizophrenia candidate
gene, human dopamine receptor D2 (DRD2) [22]. Thus, while the
T418S and L63L variants may have a role in increasing
susceptibility to an OC spectrum disorder, it may be hard to
demonstrate functional impact of these variants with in vitro
functional assays.
In contrast, the SLITRK1-N400I variant is a missense change
that in theory carries a greater risk for secondary functional
consequences and phenotypic differences. Our functional analysis
of the N400I variant in rat hippocampal neurons and in mouse
cortical neurons supports this conclusion. Wildtype SLITRK1
stimulates neurite outgrowth [4,12] and we investigated the impact
of the N400I variant on this function. Unlike the overexpressed
wildtype SLITRK1, which significantly extended the summed total
neurite length in our neurite outgrowth assays (relative to an
empty vector control, data not shown), the N400I variant showed
no activity in either E18 rat hippocampal neurons nor in E17
mouse cortical neurons. Similarly, the SLTRK1 frameshift
mutation previously observed in TS and TTM cases also failed
Figure 1. Novel mutations identified in SLITRK1. (a) Allelic frequency of novel SLITRK1 mutations identified in obsessive-compulsive disorder
(OCD) cases. (b) The SLITRK1 L63L mutation has been demonstrated by sequencing in one of 762 OC spectrum alleles and in zero of 712 control
alleles. (c) The SLITRK1 N400I mutation has been demonstrated via sequencing and genotyping in one of 646 OC spectrum alleles and in zero of 2070
control alleles, respectively; tincludes genotyping of 1358 alleles. (d) The SLITRK1 T418S mutation has been demonstrated by sequencing in three of
762 OC spectrum alleles and in one of 410 control alleles. (d) Conservation map of SLITRK1 region where the three novel mutations were identified
(Green – novel variants, gray – evolutionarily conserved regions). (e) A schematic of the SLITRK1 protein with the detected variants identified (red –
novel variants, gray – previously published variants in Tourette syndrome4, black – published variants in trichotillomania5. Dotted outline depicts
leucine rich repeat (LRR) region 9. Diagram of SLITRK1 is available at http://smart.embl-heidelberg.de. LRR typ – LRR typical subfamily, LRR CT – LRR C-
terminal domain, LRR N-terminal domain; dark blue bar – transmembrane domain.
doi:10.1371/journal.pone.0070376.g001
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to stimulate neurite outgrowth [4]. The consistent functional
alteration seen in both the SLITRK1 frameshift variant and in the
N400I variant provides support for a role for the N400I variant in
the pathophysiology in the OC spectrum. More specifically, the
amino acid change in N400I is located in one of the extracellular
leucine-rich repeat domains (a type of domain predicted to be
involved in protein-binding) and as such may disrupt the
interaction of SLITRK1 with its extracellular targets, leading to
inhibited or compromised function.
We identified the SLITRK1-T418S missense variation in four
individuals with an OCD and in one individual without an OC
spectrum disorder. Post hoc analysis revealed that the individual
without an OC spectrum disorder is afflicted with MDD, is mildly
mentally retarded and exhibits various subclinical psychiatric
phenotypes, despite the absence of an OC spectrum disorder
(Figure 2). In addition, she exhibits a pathological grooming
behavior, compulsive-nail biting, that is reminiscent of similar
grooming behaviors seen in the OC spectrum, such as compulsive
hair-pulling in TTM. Additionally, we note a potential relation-
ship between the SLITRK1-T418S variant in depression as four of
the five individuals with the T418S missense mutation (including
the non-OC spectrum individual) have a diagnosis of MDD and
the remaining individual has a history of attempted suicide
(Figure 2). However, given the high prevalence rates of depression
in the general population (9.1% current depression in the United
States [23]), the depressive symptoms and T418S connection seen
in this sample may be coincidental. Additional sequencing of
SLITRK1 in large numbers of individuals will be needed to
determine whether the T418S or other rare variants, are increased
in a broader range of psychiatric phenotypes than is represented
by the OC spectrum.
In this study we combine a comprehensive genetic screen of
SLITRK1 in OCD and closely related disorders, with the
functional analysis of a newly identified SLITRK1 missense variant
found in the screen. Using this dual approach, we documented
significantly more genetic variation in SLITRK1 in OCD than in a
non-OC spectrum comparison group; furthermore, we identified
one variant, SLITRK1-N400I, which eliminates a known function
of the protein. This represents an important advance in the
characterization of the role SLITRK1 may play in the pathophys-
Figure 2. Pedigree diagrams of families with SLITRK1 variants. Pedigrees for individuals in whom SLITRK1 variants were identified. Each
obsessive-compulsive (OC) spectrum proband is labeled with his/her identifier and is designated by a black arrowhead. Individuals affected with an
OC spectrum disorder are represented by shaded symbols, with red shading indicating obsessive-compulsive disorder (OCD) and blue shading
indicating Tourette syndrome (TS). Psychiatric conditions outside of the OC spectrum are represented by a magenta circle in the center of the symbol.
Male family members are represented with squares, females with circles, persons with unspecified gender are diamonds with the number of
individuals indicated directly below. All psychiatric pathology is listed under each affected individual. OCD – Obsessive-Compulsive Disorder, TS –
Tourette syndrome, BDD – Body Dysmorphic Disorder, GAD – Generalized Anxiety Disorder, MDD – Major Depressive Disorder, N.O.S. – not otherwise
specified, PD – Panic Disorder, PTSD – Post-Traumatic Stress Disorder, w/ - with, y/o – years old, ? – psychiatric history is unavailable for the individual.
doi:10.1371/journal.pone.0070376.g002
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iology of the OC spectrum and emphasizes the benefits of
combining genetic and functional assays to enhance our under-
standing of psychiatric illness.
Materials and Methods
Ethics Statement
This research was approved by the Ethics Committee of the
Medical Faculty, University of Bonn Biomedical Center. Informed
written consent was obtained from each participant. The consent
process was overseen and documented in accordance with the
local Research Ethics Boards. All participants who declined to
participate or did not otherwise participate were not disadvan-
taged in any way by not participating in the study. This
investigation was conducted according to the principles expressed
in the Declaration of Helsinki.
All studies involving animals were approved by local Research
Ethics Boards/IACUC at the relevant sites (Miller School of
Medicine University of Miami, Icahn School of Medicine at
Mount Sinai) and conducted according to the relevant national
and international guidelines.
Subjects
The OCD sample was derived from a large European family
study of OCD [11]. Individuals were screened for OCD symptoms
(e.g., checking, washing, need for symmetry, obsessions, etc) via a
self-rating instrument. Individuals with scores .95th percentile
were selected for direct assessment. Affected individuals were
diagnosed with OCD using direct interviews performed by trained
clinicians (psychiatrists, psychologists or doctoral level clinicians)
who completed reliability training. Diagnostic instruments used to
screen subjects and controls included the German version of the
Schedule for Affective Disorders and Schizophrenia-Lifetime
Version, Modified for the Study of Anxiety Disorders (SADS-
LA-IV) and/or the Structured Clinical Interview for DSM IV and,
for subjects with OCD, additionally, the Family Informant
Figure 3. SLITRK1 variant N400I fails to induce neurite outgrowth. (a) LS: Representative images of primary rat E18 hippocampal neurons
nucleofected with wildtype SLITRK1 or the SLITRK1–N400I variant. RS: Images are also traced to facilitate visualization of thin neurites. Scale
bar = 50 mm (b) LS: Representative images of primary mouse E17 cortical neurons nucleofected with wildtype SLITRK1 or the SLITRK1–N400I variant.
RS: Representative E17 cortical neuron trace. Scale bar = 50 mm (c) The summed total neurite length per hippocampal neuron at 7 div is shown. Each
bar on the bar graph represents pooled data of at least 50 neurons per experiment (n=3). Images are uniformly overexposed to improve neurite
visibility. (d) The summed total neurite length per cortical neuron at 3 div is shown. Each bar on the bar graph represents pooled data of at least 14–
22 neurons per experiment (n=2). Statistical significance was assessed using a student’s t-test as described under Materials and Methods. Error bars
are 95% confidence intervals. * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0070376.g003
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Schedule and Criteria (FISC) with additional sections for detailed
assessment of OCD (i.e., YBOCS), tics, TS and related disorders.
All diagnoses were made according to DSM IV criteria, using
consensus diagnosis techniques. Additional details of subject
inclusion and assessments are available [11].
Sequencing
Genomic DNA was extracted from peripheral blood samples
using standard procedures. An optimized PCR cycling protocol
was used to amplify the entire SLITRK1 coding region (available
on request). PCR product purification was completed with
QuickStepTM2 SOPE resin (Edge BioSystems, Gaithersburg,
MD). The entire coding sequence of SLITRK1 was directly
sequenced using the Applied Biosystems (ABI, Foster City, CA,
USA) BigDyeH Dye Terminator Cycle Sequencing Kit on an ABI
3730 capillary sequencer. Primers used for amplifying the full
coding length of SLITRK1 are available upon request. Sequences
were analyzed with Sequencher software (ver. 4.8, Gene Codes
Corp, Ann Arbor, Michigan, USA). Variants in SLITRK1 were
confirmed with re-sequencing fresh DNA aliquots in both
directions.
Creation of constructs
The dsRed-tagged wildtype human SLITRK1 expression vector
used in the hippocampal assay was made by subcloning the human
SLITRK1 cDNA clone (Santa Cruz Biotechnologies, SCBT,
4816570) into a dsRed N1-Express vector (Clontech, Mountain
View, CA). The green fluorescent protein (GFP)-tagged wildtype
human SLITRK1 expression vector used in the cortical neuron
analyses has been described elsewhere [12]. The N400I mutation
was introduced into both vectors by PCR-based mutagenesis and
confirmed by sequencing.
Neurite outgrowth assays
The neurite outgrowth assay was performed on E17 mouse
embryo cortical neurons as previously described [12]. Briefly,
cortical neurons were prepared from E17 mouse embryo and
hippocampal neurons were prepared from E18 rat embryo, and
the empty vector, SLITRK1 wildtype or N400I mutant vector were
nucleofected along with GFP, or the dsRed expression vector
(cortical and hippocampal neurons, respectively). Three days in
vitro (div) cortical cultures were fixed by 4% formaldehyde and
fluorescent images of neurons expressing GFP were randomly
captured. Neurite length was analyzed using Neurolucida (MBF
Bioscience, Williston, VT). At least 14 neurons were analyzed for
each group. Seven div E18 rat hippocampal cultures were fixed by
4% formaldehyde and fluorescent images were selected by a
person blind to the treatment condition. Only neurons with
pyramidal morphology and unobstructed neurites were analyzed.
At least 50 dsRed positive neurons within each condition were
reconstructed on a confocal microscope (Zeiss LSM 710 micro-
scope, 406 oil objective) and traced with the Simple Neuron
Tracer ImageJ plugin [24].
Statistics
Chi-square statistics to compare the sequencing and genotyping
results in individuals with OCD and controls were generated on
contingency tables using GraphPad Prism version 5.00 for
Windows (GraphPad Software, San Diego, California, USA).
Statistical analysis on quantitative neurite data was carried out
using independent student’s t-tests with a significance level of
p,0.05 using PAWS/SPSS Statistics 18.0 software (IBM Corpo-
ration, Somers, NY, USA) and/or GraphPad Prism 5.00. The
hippocampal summed total neurite length data was non-normally
distributed and these data were transformed using a logarithmic
transformation. All reported data (excluding t-values) are back-
transformed unless otherwise stated.
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